CAS 1441000-45-8

Fórmula: C21H34N2O5

InChI: InChI=1S/C21H34N2O5/c1-6-7-10-28-19-17(25-4)13-16(14-18(19)26-5)20(24)22-15-21(23(2)3)8-11-27-12-9-21/h13-14H,6-12,15H2,1-5H3,(H,22,24)

Chave InChI: JQUVQWMHZSYCRQ-UHFFFAOYSA-N

SMILES: CCCCOC1=C(C=C(C=C1OC)C(=O)NCC2(CCOCC2)N(C)C)OC

4-Butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide

CAS: 1441000-45-8

4-Butoxy-N-[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamide (BDMOB) is a molecule that has been shown to act as a serotonin receptor agonist. It has been shown to have antidepressant effects in animal models of depression and is currently in clinical development for the treatment of depression. BDMOB also has anti-nociceptive activity, which may be due to its ability to inhibit the release of proinflammatory cytokines from macrophages and microglial cells. This drug also inhibits cancer cell growth and chronic pain.

Fórmula: C₂₁H₃₄N₂O₅

Pureza: Min. 95%

Peso molecular: 394.5 g/mol

Ref: 3D-RHC00045

Opiranserin

CAS: 1441000-45-8

Opiranserin is a development as an injectable agent for the treatment of postoperative pain.

Fórmula: C₂₁H₃₄N₂O₅

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 394.51

Ref: TM-T16399